At WEHI, we are working hard every day to bring these prostate cancer numbers down and, one day, eradicate all forms of cancer for good.
We are currently collaborating with the global Pan-Prostate Cancer Group to analyse the largest prostate cancer data project ever undertaken.
Our goal is to understand what causes prostate cancer, how it changes as it progresses, and exactly what determines outcomes.
Our aim is to discover better methods of prevention, diagnosis and treatment for men everywhere.
WEHI researchers, Professor Tony Papenfuss and PhD student, Jennifer Ureta are focusing their efforts on a prevailing anomaly within the realm of cancer: oncogene amplification. This is the process where certain genes, known as oncogenes, abnormally increase the number of copies of the gene within a cell’s DNA.
Our researchers are interested in understanding the mechanisms behind oncogene amplification in prostate cancer because it can provide valuable insights into the drivers of this disease, with the ultimate goal of improving prevention, diagnosis and treatment.